Antiproliferative effect of vitamin A and D analogues on adult human keratinocytes in vitro

Skin Pharmacology and Physiology

Volumn 21, Issue 4, 2008, Pages 227-234

  Popadic, S ^a   Ramic, Z ^a   Medenica, L ^a   Mostarica Stojkovic, M ^a   Trajkovic V ^a   Popadic, D ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Adult keratinocytes, in vitro; Apoptosis; Cholecalciferol; Ergocalciferol; Proliferation; Retinoids

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; FLUORESCEIN DIACETATE; ISOTRETINOIN; RETINOIC ACID; RETINOID; RETINOL; RETINOL DERIVATIVE; TRYPAN BLUE; VITAMIN D; VITAMIN D DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; HOMEOSTASIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; KERATINOCYTE; PRIORITY JOURNAL;

APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CHOLECALCIFEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOCALCIFEROLS; HUMANS; ISOTRETINOIN; KERATINOCYTES; TRETINOIN; VITAMIN A; VITAMIN D;

EID: 47249109336     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135639     Document Type: Article

References (37)

1. Zhang JZ, Maruyama K, Ono I, Iwatsuki K, Kaneko F: Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 α (IL-1 α) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1). J Dermatol Sci 1994;7:24-31.
2. Ruzicka T, Larsen FG, Galewicz D, Horvath A, Coenraads PJ, Thestrup-Pedersen K, Ortonne JP, Zouboulis CC, Harsch M, Brown TC, Zultak M: Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004;140:1453-1459.
3. Sebag M, Gulliver W, Kremer R: Effect of 1,25 dihyroxyvitamin D3 and calcium on growth and differentiation and on c-fos and p53 gene expression in normal human keratinocytes. J Invest Dermatol 1994;103:323-329.
4. Bikle DD: 1,25(OH) 2 D 3 -modulated calcium induced keratinocyte differentiation. J Investig Dermatol Symp Proc 1996;1:22-27.
5. Mitani H, Naru E, Yamashita M, Arakane K, Suzuki T, Imanari T: Ergocalciferol promotes in vivo differentiation of keratinocytes and reduces photodamage caused by ultraviolet irradiation in hairless mice. Photodermatol Photoimmunol Photomed 2004;20:215-223.
6. Van der Kerkhof PCM: Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995;132:675-682.
7. Norsgaard H, Haake AR, Cooklis M: Incomplete differentiation of fetal keratinocytes in the skin equivalent leads to the default pathway of apoptosis. Exp Cell Res 1997;231:83-95.
8. Mrass P, Rendl M, Mildner M, Gruber F, Lengauer B, Ballaun C, Eckhart L, Tschachler E: Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res 2004;64:6542-6548.
9. Napoli JL: Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clin Immunol Immunopathol 1996;80:S52-S62.
10. Sorensen S, Solvsten H, Politi Y, Kragballe K: Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors. Skin Pharmacol 1997;10:144-152.
11. Eichner R, Gendimenico GJ, Kahn M, Mallon JP, Capetola RJ, Mezick JA: Effects of long-term retinoic acid treatment on epidermal differentiation in vivo: specific modifications in the programme of terminal differentiation. Br J Dermatol 1996;135:687-695.
12. Yu VC, Delsert C, Andersen B, Holloway JM, Devary OV, Naar AM, Kim SY, Boutin JM, Glass CK, Rosenfeld MG: RXR β: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 1991;67:1251-1266.
13. Komine M, Watabe Y, Shimaoka S, Sato F, Kake K, Nishina H, Ohtsuki M, Nakagawa H, Tamaki K: The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch Dermatol Res 1999;291:500-506.
14. Gibson DF, Bikle DD, Harris J: All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes. J Cell Physiol 1998;174:1-8.
15. Bourke JF, Mumford R, Whittaker P, Iqbal SJ, Le Van LW, Trevellyan A, Hutchinson PE: The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis. J Am Acad Dermatol 1997;37:929-934.
16. Lowe NJ: When systemic retinoids fail to work in psoriasis; in Saurat JJ (ed): Retinoids: 10 Years On. Basel, Karger, 1991, pp 341-349.
17. Popadic S, Popadic D, Ramic Z, Mostarica Stojkovic M, Trajkovic V, Milinkovic M, Medenica L: Chloramphenicol induces in vitro growth arrest and apoptosis of human keratinocytes. Cell Biol Toxicol 2006;22:371-379.
18. Drewinko B, Loo TL, Brown B, Gottlieb JA, Freireich EJ: Combination chemotherapy in vitro with adriamycin: observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Cancer Biochem Biophys 1976;1:187-195.
19. Barzanti F, Zoli W, Susino MD, Ricotti L, Tesei A, Papa S, Reno F, Amadori D: Simultaneous determination of apoptosis and surface antigen expression in tumor adherent cells. J Biol Regul Homeost Agents 2001;15:359-365.
20. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-798.
21. Islam TC, Skarin T, Sumitran S, Toftgard R: Retinoids induce apoptosis in cultured keratinocytes. Br J Dermatol 2000;143:709-719.
22. Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A: Cytokine expression by epidermal cell subpopulations. J Invest Dermatol 1992;99:42-45.
23. Pol A, Bergers M, Schalkwijk J: Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay. In Vitro Cell Dev Biol Anim 2003;39:36-42.
24. Varani J, Nickoloff BJ, Dixit VM, Mitra RS, Voorhees JJ: All- trans retinoic acid stimulates growth of adult human keratinocytes cultured in growth factor-deficient medium, inhibits production of thrombospondin and fibronectin, and reduces adhesion. J Invest Dermatol 1989;93:449-454.
25. Zellmer S, Reissig D: Isolation, cultivation, and differentiation of normal human epidermal keratinocytes in serum-free medium. Methods Mol Biol 2002;188:179-184.
26. Peck G: The retinoids; in Freedberg IM, Eisen AZ, Wolff K (eds): Fitzpatrick's Dermatology in General Medicine. New York, McGraw-Hill, 1999, vol 2, pp 2810-2821.
27. Smith JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC: Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin. J Am Acad Dermatol 2004;51:257-264.
28. Pluff D, Dunham WR, Marcelo CL, Kageyama H: Cholera toxin and retinoic acid slow the growth rate of human keratinocytes in low-calcium, serum-free culture. J Dermatol Sci 2004;34:59-61.
29. Jones G, Byford V, Makin HL, Kremer R, Rice RH, de Graffenried LA, Knutson JC, Bishop CW: Anti-proliferative activity and target cell catabolism of the vitamin D analog 1α,24(S)-(OH)2D2 in normal and immortalized human epidermal cells. Biochem Pharmacol 1996;52:133-140.
30. Manggau M, Kim DS, Ruwisch L, Vogler R, Korting HC, Schafer-Korting M, Kleuser B: 1α,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol 2001;117:1241-1249.
31. Takahashi H, Tamura T, Iizuka H: 1α,25-dihydroxyvitamin D3 increased β-adrenergic adenylate cyclase response of fetal rat keratinizing epidermal cells (FRSK cells). J Dermatol Sci 1996;11:121-128.
32. Tang L, Yu Y, Chen J, Li Q, Yan M, Guo Z: The inhibitory effect of VitD3 on proliferation of keratinocyte cell line HACAT is mediated by down-regulation of CXCR2 expression. Clin Exp Dermatol 2003;28:416-419.
33. Takahashi H, Ibe M, Kinouchi M, Yamamoto AI, Hashimoto Y, Iizuka H: Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. J Dermatol Sci 2003;31:21-28.
34. Lehmann B, Rudolph T, Pietzsch J, Meurer M: Conversion of vitamin D3 to 1α,25-dihydroxyvitamin D3 in human skin equivalents. Exp Dermatol 2000;9:97-103.
35. Moll PR, Sander V, Frischauf AM, Richter K: Expression profiling of vitamin D treated primary human keratinocytes. J Cell Biochem 2007;100:574-592.
36. Hail N Jr, Lotan R: Synthetic retinoid CD437 promotes rapid apoptosis in malignant human epidermal keratinocytes and G1 arrest in their normal counterparts. J Cell Physiol 2001;186:24-34.
37. Segaert S, Garmyn M, Degreef H, Bouillon R: Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. J Invest Dermatol 1997;109:46-54.